Kamaraj Balu, Bogaerts Annemie
Research group PLASMANT, Department of Chemistry, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk-Antwerp, Belgium.
PLoS One. 2015 Aug 5;10(8):e0134638. doi: 10.1371/journal.pone.0134638. eCollection 2015.
The tumor suppressor protein p53 can lose its function upon DNA-contact mutations (R273C and R273H) in the core DNA-binding domain. The activity can be restored by second-site suppressor or rescue mutations (R273C_T284R, R273H_T284R, and R273H_S240R). In this paper, we elucidate the structural and functional consequence of p53 proteins upon DNA-contact mutations and rescue mutations and the underlying mechanisms at the atomic level by means of molecular dynamics simulations. Furthermore, we also apply the docking approach to investigate the binding phenomena between the p53 protein and DNA upon DNA-contact mutations and rescue mutations. This study clearly illustrates that, due to DNA-contact mutants, the p53 structure loses its stability and becomes more rigid than the native protein. This structural loss might affect the p53-DNA interaction and leads to inhibition of the cancer suppression. Rescue mutants (R273C_T284R, R273H_T284R and R273H_S240R) can restore the functional activity of the p53 protein upon DNA-contact mutations and show a good interaction between the p53 protein and a DNA molecule, which may lead to reactivate the cancer suppression function. Understanding the effects of p53 cancer and rescue mutations at the molecular level will be helpful for designing drugs for p53 associated cancer diseases. These drugs should be designed so that they can help to inhibit the abnormal function of the p53 protein and to reactivate the p53 function (cell apoptosis) to treat human cancer.
肿瘤抑制蛋白p53在核心DNA结合域发生DNA接触突变(R273C和R273H)时会失去其功能。第二位点抑制或拯救突变(R273C_T284R、R273H_T284R和R273H_S240R)可恢复其活性。在本文中,我们通过分子动力学模拟在原子水平上阐明了DNA接触突变和拯救突变对p53蛋白的结构和功能影响及其潜在机制。此外,我们还应用对接方法研究了DNA接触突变和拯救突变时p53蛋白与DNA之间的结合现象。这项研究清楚地表明,由于DNA接触突变体,p53结构失去稳定性,比天然蛋白更僵硬。这种结构变化可能会影响p53与DNA的相互作用并导致癌症抑制作用的抑制。拯救突变体(R273C_T284R、R273H_T284R和R273H_S240R)可在DNA接触突变时恢复p53蛋白的功能活性,并显示p53蛋白与DNA分子之间有良好的相互作用,这可能会导致癌症抑制功能重新激活。在分子水平上了解p53癌症和拯救突变的影响将有助于设计针对p53相关癌症疾病的药物。这些药物的设计应使其能够帮助抑制p53蛋白的异常功能并重新激活p53功能(细胞凋亡)以治疗人类癌症。